WO2009014207A1 - 猫免疫不全ウイルスワクチン接種猫の検査方法、および該検査用抗原 - Google Patents

猫免疫不全ウイルスワクチン接種猫の検査方法、および該検査用抗原 Download PDF

Info

Publication number
WO2009014207A1
WO2009014207A1 PCT/JP2008/063383 JP2008063383W WO2009014207A1 WO 2009014207 A1 WO2009014207 A1 WO 2009014207A1 JP 2008063383 W JP2008063383 W JP 2008063383W WO 2009014207 A1 WO2009014207 A1 WO 2009014207A1
Authority
WO
WIPO (PCT)
Prior art keywords
feline
fiv
vaccinated
test
antigen
Prior art date
Application number
PCT/JP2008/063383
Other languages
English (en)
French (fr)
Inventor
Tsutomu Hohdatsu
Kenji Motokawa
Hajime Kusuhara
Original Assignee
The Kitasato Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Kitasato Institute filed Critical The Kitasato Institute
Priority to US12/670,592 priority Critical patent/US8394581B2/en
Priority to JP2009524521A priority patent/JP5409361B2/ja
Priority to AU2008280898A priority patent/AU2008280898B2/en
Priority to EP08791627A priority patent/EP2175271A4/en
Priority to CA2693305A priority patent/CA2693305A1/en
Publication of WO2009014207A1 publication Critical patent/WO2009014207A1/ja

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1036—Retroviridae, e.g. leukemia viruses
    • C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56988—HIV or HTLV
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/15—Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus, feline leukaemia virus, human T-cell leukaemia-lymphoma virus
    • G01N2333/155—Lentiviridae, e.g. visna-maedi virus, equine infectious virus, FIV, SIV
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • AIDS & HIV (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

　FIVワクチンを接種した猫は、FIVに対する抗体を産生するため、FIV及びFIV由来物質を用いた血清学的診断法では、FIV感染猫と区別することは難しい。本発明では、猫へのFIVワクチンの接種により産生され、FIV感染によっては産生されない抗体を検出することにより、猫のFIVワクチン接種歴の有無を検査することを可能とした。本発明の方法により、抗FIV抗体陽性猫が、FIVに感染しているのか、ワクチン接種によるものなのかを簡便に区別することが可能である。
PCT/JP2008/063383 2007-07-25 2008-07-25 猫免疫不全ウイルスワクチン接種猫の検査方法、および該検査用抗原 WO2009014207A1 (ja)

Priority Applications (5)

Application Number Priority Date Filing Date Title
US12/670,592 US8394581B2 (en) 2007-07-25 2008-07-25 Test method on feline vaccinated with feline immunodeficiency virus vaccine, and antigen for use in the test
JP2009524521A JP5409361B2 (ja) 2007-07-25 2008-07-25 猫免疫不全ウイルスワクチン接種猫の検査方法、および該検査用抗原
AU2008280898A AU2008280898B2 (en) 2007-07-25 2008-07-25 Test method on feline vaccinated with feline immunodeficiency virus vaccine, and antigen for use in the test
EP08791627A EP2175271A4 (en) 2007-07-25 2008-07-25 ASSAY PROCEDURE ON A CAT STICKED WITH A VACCINE AGAINST FELINES IMMUNODEFICIENCY AND ANTIGEN FOR USE IN THE TEST
CA2693305A CA2693305A1 (en) 2007-07-25 2008-07-25 Test method on feline vaccinated with feline immunodeficiency virus vaccine, and antigen for use in the test

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2007192975 2007-07-25
JP2007-192975 2007-07-25

Publications (1)

Publication Number Publication Date
WO2009014207A1 true WO2009014207A1 (ja) 2009-01-29

Family

ID=40281454

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2008/063383 WO2009014207A1 (ja) 2007-07-25 2008-07-25 猫免疫不全ウイルスワクチン接種猫の検査方法、および該検査用抗原

Country Status (6)

Country Link
US (1) US8394581B2 (ja)
EP (1) EP2175271A4 (ja)
JP (1) JP5409361B2 (ja)
AU (1) AU2008280898B2 (ja)
CA (1) CA2693305A1 (ja)
WO (1) WO2009014207A1 (ja)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115825434B (zh) * 2022-09-30 2023-08-22 杭州瑞测生物技术有限公司 一种抗原抗体联检的可凝集猫红细胞的猫艾滋检测试剂卡及其检测方法

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07159408A (ja) * 1993-12-09 1995-06-23 Biseibutsu Kagaku Kenkyusho:Kk オーエスキー病ウイルス感染抗体識別用抗原
JPH11513031A (ja) * 1995-08-25 1999-11-09 ユニバーシティー オブ フロリダ 多種サブタイプｆｉｖワクチン
WO2006011917A1 (en) * 2004-06-30 2006-02-02 Idexx Laboratories, Inc. Method and device for detecting feline immunodeficiency virus
JP2007514753A (ja) * 2003-12-18 2007-06-07 アイデックス ラボラトリーズ インコーポレイテッド ネコ免疫不全ウイルスの検出のための方法と装置

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6461616B1 (en) * 2000-09-09 2002-10-08 Akzo Nobel Nv EIAV p26 deletion vaccine and diagnostic

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07159408A (ja) * 1993-12-09 1995-06-23 Biseibutsu Kagaku Kenkyusho:Kk オーエスキー病ウイルス感染抗体識別用抗原
JPH11513031A (ja) * 1995-08-25 1999-11-09 ユニバーシティー オブ フロリダ 多種サブタイプｆｉｖワクチン
JP2007514753A (ja) * 2003-12-18 2007-06-07 アイデックス ラボラトリーズ インコーポレイテッド ネコ免疫不全ウイルスの検出のための方法と装置
WO2006011917A1 (en) * 2004-06-30 2006-02-02 Idexx Laboratories, Inc. Method and device for detecting feline immunodeficiency virus

Non-Patent Citations (11)

* Cited by examiner, † Cited by third party
Title
B. WALDERS ET AL., 1 RESEARCH IN VETERINARY SCIENCE, vol. 78, 2005, pages 135 - 141
FONTENOT, J. D.; HOOVER, E. A.; ELDER, J. H.; MONTELARO, R. C.: "Evaluation of feline immunodeficiency virus and feline leukemia virus transmembrane peptides for serological diagnosis", J. CLIN. MICROBIOL., vol. 30, 1992, pages 1885 - 1890
HOHDATSU T; OKADA S; MOTOKAWA K; AIZAWA C; YAMAMOTO JK; KOYAMA H.: "Effect of dual-subtype vaccine against feline immunodeficiency virus infection", VET. MICROBIOL., vol. 58, no. 2-4, 1997, pages 155 - 165
HOTATSU T.: "FIV Vaccine no Genjo to Rinsho Oyo", DAI 141 KAI JAPANESE SOCIETY OF VETERIANY SCIENCE GAKUJUTSU SHUKAI KOEN YOSHISHU, 1 March 2006 (2006-03-01), pages 159 + ABSTR. NO. HS2-4 *
KUSUHARA H. ET AL.: "Feline immunodeficiency virus (FIV) Dual-Subtype Fukatsuka Vaccine (Fel-O-Vax FIV) Chusha Neko to FIV Kansen Neko no Kesseigakuteki Kanbetsu", DAI 140 KAI JAPANESE SOCIETY OF VETERIANY SCIENCE GAKUJUTSU SHUKAI KOEN YOSHISHU, 31 August 2005 (2005-08-31), pages 110 + ABSTR. NO. DV-48 *
MERZA M. ET AL.: "Immunoaffinity purification of two major proteins of bovine leukemia virus (gp51 and p24) and their use for discrimination between vaccinated and infected animals", J. VIROL. METHODS, vol. 33, 1991, pages 345 - 353, XP023695879 *
MURRAY D.M., J. AM. VET. MED. ASSOC., vol. 222, no. 6, 15 March 2003 (2003-03-15), pages 710, XP008040878 *
PU R; COLEMAN J; OMORI M; ARAI M; HOHDATSU T; HUANG C; TANABE T; YAMAMOTO JK.: "Dual-subtype FIV vaccine protects cats against in vivo swarms of both homologous and heterologous subtype FIV isolates", AIDS, vol. 15, no. 10, 2001, pages 1225 - 1237
ROVINSKI B. ET AL.: "Engineering of noninfectious HIV-1-like particles containing mutant gp41 glycoproteins as vaccine candidates that allow vaccinees to be distinguished from HIV-1 infectees", VIROLOGY, vol. 257, 1999, pages 438 - 448, XP004439955 *
See also references of EP2175271A4
UHL, E. W.; HEATON-JONES, T. G.; PU, R.; YAMAMOTO, J. K.: "FIV vaccine development and its importance to veterinary and human medicine: a review FIV vaccine 2002 update and review", VET. IMMUNOL. IMMUNOPATHOL., vol. 90, 2002, pages 113 - 132

Also Published As

Publication number Publication date
US20100267047A1 (en) 2010-10-21
JPWO2009014207A1 (ja) 2010-10-07
AU2008280898B2 (en) 2013-06-27
CA2693305A1 (en) 2009-01-29
EP2175271A4 (en) 2010-07-21
AU2008280898A1 (en) 2009-01-29
US8394581B2 (en) 2013-03-12
JP5409361B2 (ja) 2014-02-05
EP2175271A1 (en) 2010-04-14

Similar Documents

Publication Publication Date Title
Zhang et al. Identification of an ideal adjuvant for receptor-binding domain-based subunit vaccines against Middle East respiratory syndrome coronavirus
TW200512457A (en) Method of diagnosing SARS corona virus infection
WO2001096595A3 (de) Verfahren zum nachweis von influenza a/b-viren aus speichel
WO2013165972A3 (en) Anti-hepatitis b virus antibodies and use thereof
TW200604526A (en) Identifying virally infected and vaccinated organisms
EA201590184A1 (ru) Вакцина на основе микобактериальных антигенов
WO2017079479A8 (en) Neutralizing antibodies to hiv-1 gp41 and their use
MX2014011504A (es) Metodos para la deteccion de anticuerpos neutralizantes anticitomegalovirus.
MX2019001767A (es) Anticuerpos monoclonales que se unen al dominio de union a lipidos de la proteina de la capside del virus de la hepatitis c (vhc).
EP4365311A3 (en) Methods of detecting lentivirus
CY1111521T1 (el) Λοιμογονος συστηματικος καλυκοϊος αιλουροειδων
EP2559762A4 (en) NEW MONOCLONAL ANTIBODY ANTI-HSP90
WO2007066188A3 (en) Marked bovine viral diarrhea virus vaccines
WO2009014207A1 (ja) 猫免疫不全ウイルスワクチン接種猫の検査方法、および該検査用抗原
WO2006117538A3 (en) Assays for diagnosis of tuberculosis and uses thereof
WO2011100408A3 (en) Serologic correlates of protection against bacillis anthracis infection
WO2009137871A8 (en) Methods of detecting cells with a disrupted cell membrane, cells infected with a pathogen, dying cells or dead cells
WO2007122517A3 (en) Influenza h5 pseudotyped lentiviruses and uses thereof
WO2012051372A3 (en) Immunoreactive antigens of mycoplasma heamofelis and diagnostic immunoassay
EA201991843A1 (ru) Способ иммунологического определения специфических антител к антигенам вирусов семейства поксвирусов
WO2012114312A3 (en) Exogenous internal positive control
TW200722527A (en) Methods of detecting hepatitis C virus
WO2005024427A3 (en) Detection of west nile virus infection and vaccination
WO2005062053A3 (en) Method and device for detecting feline immunodeficiency virus
WO2005080939A3 (en) Method and device for detecting feline immunodeficiency virus

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08791627

Country of ref document: EP

Kind code of ref document: A1

ENP Entry into the national phase

Ref document number: 2009524521

Country of ref document: JP

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 2693305

Country of ref document: CA

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2008280898

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 2008791627

Country of ref document: EP

ENP Entry into the national phase

Ref document number: 2008280898

Country of ref document: AU

Date of ref document: 20080725

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 12670592

Country of ref document: US